To Compare the Efficacy and Safety of Intravenous Tramadol versus Intravenous Paracetamol as Analgesics in Patients of Acute Pancreatitis: A Prospective, Randomized Control Trial

patient will be randomized 1:1 and one group will receive iv paracetamol 1000 mg/100 ml, and another group will get iv tramadol 50 mg/100 ml NS and will be monitored at 24 hours, 48 hours, 72 hours, and 7 days. Radiological investigations (USG, CT, MRCP) will determine the severity of Acute Pancreatitis as per the Revised Atlanta Classification 2012 (mild, moderate to Severe, Severe). Extensive laboratory tests like CBC, LFT, ABG, Urine- analysis, lipid profile, blood glucose, GGT,  serum procalcitonin, SGPT, SGOT, serum bilirubin (direct, indirect, and total), serum amylase, and serum lipase will be conducted. Pain intensity will be assessed using a Visual Analogue Scale at the baseline and at 24 hours, 48 hours, 72 hours, and 7 days if possible, with recorded changes. The comprehensive approach provides insights into the effectiveness of IV paracetamol and Tramadol in managing pain among patients with acute pancreatitis, regardless of severity. It also evaluates secondary outcomes, including duration of pain relief, impact on hospital stays, and patient satisfaction with pain management.